A systematic review in npj Aging consolidates the evidence on brain health among people who reach 100 years, a population in which cognitive performance varies widely and neuropathological burden does not reliably predict function. The review frames centenarian cognition as a model of resilience rather than simple absence of disease, with implications for how late-life brain aging is assessed and supported.
Key Points
- Centenarian cognition ranges from intact to severely impaired
- Neuropathology present without proportional cognitive decline in many cases
- Resilience, not disease absence, characterizes preserved late-life cognition
Longevity Analysis
Reaching extreme age with intact cognition appears to depend less on avoiding pathology than on maintaining the capacity to function despite it — a distinction that shifts attention toward vascular integrity, clearance of metabolic waste during sleep, and sustained neural repair rather than any single disease target. Cognitive testing in the tenth decade also requires interpretation adjusted for sensory loss and slowed processing, since function is routinely misread when standard norms are applied. For those decades away from this stage, the practical implication is that the substrate of late-life cognitive reserve is built through consistent cardiovascular, metabolic, and sleep maintenance rather than late intervention.
Original published by Nature - npj Aging, by Sandra Milena Castelblanco-Toro.